Skip Nav Destination
            
    
            
 
    
    
        
            
                
                    
                        
                        
                            
                        
                    
                
                    
                    
                        
                    
                
                
                    
                        
                        
                            
                        
                    
            
        
    
    
    
        
        
        
    
        
        
    
        
 
    
 
    
        
    
    
        
            
        
        
    
        
    
    
    
 
    
                
                    
            
    
        
    
    
                     
    
                    
        
        
        
        Arterial thromboembolic events preceding the diagnosis of cancer in older persons
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                     
    
                    
        
                    
                
            
    
    
    
        
        
     
    
                     
    
                    
        
                    
                
            
    
    
    
        
        
     
    
                    
                    
        
        Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
        
        
            
        
    
        
                
            
    
    
    
        
        
     
    
                     
    
                     
    
                     
    
                     
    
                    
        
        
     
    
                     
    
 
    
            
    
        
    
         
 
    
    
        
    
            
    
        
    
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
        
    
    
    
            
        
 
    
    
 
    
    
         
    
    
        
    
    
    
            
    
                    
 
    
    
 
    
    
 
    
    
    
    
        
    Issue Archive
February 21 2019
    
    In this Issue
    
    Table of Contents
BLOOD COMMENTARIES
PLENARY PAPER
CLINICAL TRIALS AND OBSERVATIONS
                    
        
        Arterial thromboembolic events preceding the diagnosis of cancer in older persons
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Babak B. Navi,Anne S. Reiner,Hooman Kamel,Costantino Iadecola,Peter M. Okin,Scott T. Tagawa,Katherine S. Panageas,Lisa M. DeAngelis
            
        
    
            BLOOD SPOTLIGHT
HOW I TREAT
HEMATOPOIESIS AND STEM CELLS
BCAS2 is essential for hematopoietic stem and progenitor cell maintenance during zebrafish embryogenesis
            Shanshan Yu,Tao Jiang,Danna Jia,Yunqiao Han,Fei Liu,Yuwen Huang,Zhen Qu,Yuntong Zhao,Jiayi Tu,Yuexia Lv,Jingzhen Li,Xuebin Hu,Zhaojing Lu,Shanshan Han,Yayun Qin,Xiliang Liu,Shanglun Xie,Qing K. Wang,Zhaohui Tang,Daji Luo,Mugen Liu
            
        
    
            IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
FBXW7 mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLL
            Viola Close,William Close,Sabrina Julia Kugler,Michaela Reichenzeller,Deyan Yordanov Yosifov,Johannes Bloehdorn,Leiling Pan,Eugen Tausch,Mike-Andrew Westhoff,Hartmut Döhner,Stephan Stilgenbauer,Franz Oswald,Daniel Mertens
            
        
    
            MYELOID NEOPLASIA
        
        Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
        
        
            
        
                    
                        Clinical Trials & Observations
                    
        
            
    
        
            Richard F. Schlenk,on behalf of the German-Austrian AML Study Group,Daniela Weber,on behalf of the German-Austrian AML Study Group,Walter Fiedler,on behalf of the German-Austrian AML Study Group,Helmut R. Salih,on behalf of the German-Austrian AML Study Group,Gerald Wulf,on behalf of the German-Austrian AML Study Group,Hans Salwender,on behalf of the German-Austrian AML Study Group,Thomas Schroeder,on behalf of the German-Austrian AML Study Group,Thomas Kindler,on behalf of the German-Austrian AML Study Group,Michael Lübbert,on behalf of the German-Austrian AML Study Group,Dominik Wolf,on behalf of the German-Austrian AML Study Group,Jörg Westermann,on behalf of the German-Austrian AML Study Group,Doris Kraemer,on behalf of the German-Austrian AML Study Group,Katharina S. Götze,on behalf of the German-Austrian AML Study Group,Heinz-August Horst,on behalf of the German-Austrian AML Study Group,Jürgen Krauter,on behalf of the German-Austrian AML Study Group,Michael Girschikofsky,on behalf of the German-Austrian AML Study Group,Mark Ringhoffer,on behalf of the German-Austrian AML Study Group,Thomas Südhoff,on behalf of the German-Austrian AML Study Group,Gerhard Held,on behalf of the German-Austrian AML Study Group,Hans-Günter Derigs,on behalf of the German-Austrian AML Study Group,Roland Schroers,on behalf of the German-Austrian AML Study Group,Richard Greil,on behalf of the German-Austrian AML Study Group,Martin Grießhammer,on behalf of the German-Austrian AML Study Group,Elisabeth Lange,on behalf of the German-Austrian AML Study Group,Alexander Burchardt,on behalf of the German-Austrian AML Study Group,Uwe Martens,on behalf of the German-Austrian AML Study Group,Bernd Hertenstein,on behalf of the German-Austrian AML Study Group,Lore Marretta,on behalf of the German-Austrian AML Study Group,Michael Heuser,on behalf of the German-Austrian AML Study Group,Felicitas Thol,on behalf of the German-Austrian AML Study Group,Verena I. Gaidzik,on behalf of the German-Austrian AML Study Group,Wolfgang Herr,on behalf of the German-Austrian AML Study Group,Julia Krzykalla,on behalf of the German-Austrian AML Study Group,Axel Benner,on behalf of the German-Austrian AML Study Group,Konstanze Döhner,on behalf of the German-Austrian AML Study Group,Arnold Ganser,on behalf of the German-Austrian AML Study Group,Peter Paschka,on behalf of the German-Austrian AML Study Group,Hartmut Döhner,on behalf of the German-Austrian AML Study Group
            
        
    
            RED CELLS, IRON, AND ERYTHROPOIESIS
THROMBOSIS AND HEMOSTASIS
TRANSPLANTATION
LETTER TO BLOOD
BLOOD WORK
CONTINUING MEDICAL EDUCATION (CME) QUESTIONS
- 
        
            Cover Image
        
        Cover Image![issue cover]()  This whole-mount in situ hybridization image with a probe targeting cmyb (cellular progenitor of the avian myeloblastosis virus oncogene) reveals a reduced number of hematopoietic stem and progenitor cells in the caudal hematopoietic tissue of bcas2 (breast carcinoma amplified sequence 2) knockout zebrafish embryos 3 days after fertilization. See the article by Yu et al on page 805. 
- PDF Icon Front MatterFront Matter
- PDF Icon Table of ContentsTable of Contents
- PDF Icon Back MatterBack Matter
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
 
                    








